EndoStim, Inc., a St. Louis medical device startup, is using technology developed by ASU engineering professor Bruce Towe to develop implantable microelectronic devices to help treat acid reflux, urinary incontinence and sexual dysfunction through local neurostimulation. These disorders affect hundreds of millions of people worldwide. “The patented technology licensed from AzTE will significantly advance our commercial development of highly miniaturized neurostimulators that can be delivered with a minimally invasive procedure in an outpatient setting,” said Bevil Hogg, EndoStim’s President and CEO. ASU’s technology was an important factor in EndoStim’s raising more than $6 million in Series B equity financing this year. The company plans to use the funding to continue clinical trials overseas and pursue FDA approval for these devices.